Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.
BMC Cancer
; 23(1): 767, 2023 Aug 18.
Article
in En
| MEDLINE
| ID: mdl-37596517
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Lymphoma
Type of study:
Clinical_trials
Aspects:
Patient_preference
Limits:
Aged
/
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Affiliation country:
Alemania